Analyst firms · Raymond James · HR
Raymond James HR price target and rating history
Healthcare Realty Trust Incorporated (HR) · Real Estate
Raymond James rates Healthcare Realty Trust Incorporated (HR) Outperform with a $24 price target, as of its latest action on Jun 17, 2026. It has published 3 rating actions on HR since August 2021, including 0 upgrades and 2 downgrades. Across 4 firms with a HR price target in the last 12 months, the median target is $21.50. Raymond James's $24 is 12% above that.
- Current rating
- Outperform
- Price target
- $24
- Median target, all firms
- $21.50
- Actions on HR
- 3
Every Raymond James rating on HR
- Jun 17, 2026
- Sep 15, 2025
- Aug 20, 2021
How other firms rate HR
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Deutsche Bank | Buy | $23 | Oct 20, 2026 |
| Jefferies | Hold | $20 | Sep 15, 2026 |
| Raymond James | Outperform | $24 | Jun 17, 2026 |
| UBS | Neutral | $18 | Apr 20, 2026 |
Questions about Raymond James and HR
- What is Raymond James's price target for HR?
- Raymond James's latest stated price target for Healthcare Realty Trust Incorporated (HR) is $24, from its action on Jun 17, 2026.
- What is Raymond James's rating on HR?
- Raymond James rates HR Outperform, a bullish rating, as of Jun 17, 2026.
- When did Raymond James last change its view on HR?
- On Jun 17, 2026, Raymond James resumes coverage at Outperform, price target $24.
- How does Raymond James's HR target compare with other analysts?
- Across 4 firms with a HR price target in the last 12 months, the median target is $21.50. Raymond James's $24 is 12% above that.
More HR rating histories
All Raymond James ratingsHR news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.